Therapeutic trials in muscular dystrophy. I. Gold in murine dystrophy

A. Enomoto; W. G. Bradley

doi:10.1136/jnnp.41.5.404

Therapeutic trials in muscular dystrophy. I. Gold in murine dystrophy

A. Enomoto, W. G. Bradley

Neurology

Research output: Contribution to journal › Article

1 Scopus citations

Abstract

A trial of sodium aurothiomalate as an antiproteinase drug in the treatment of murine muscular dystrophy is reported. A blind controlled comparison of high (25 μg/10 g body weight) and low dose gold (5 μg/10 g body weight) with saline-injected control animals was made, all injections being given 3 times weekly. The body weights and functional ability of the mice were assessed at weekly intervals. No significant difference between the groups was observed. A trial of very high dose chrysotherapy (500 μg of gold/10 g body weight) also showed no therapeutic benefit.

Original language	English (US)
Pages (from-to)	404-407
Number of pages	4
Journal	Journal of Neurology Neurosurgery and Psychiatry
Volume	41
Issue number	5
DOIs	https://doi.org/10.1136/jnnp.41.5.404
State	Published - 1978

ASJC Scopus subject areas

Surgery
Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1136/jnnp.41.5.404

Fingerprint Dive into the research topics of 'Therapeutic trials in muscular dystrophy. I. Gold in murine dystrophy'. Together they form a unique fingerprint.

Cite this

Enomoto, A., & Bradley, W. G. (1978). Therapeutic trials in muscular dystrophy. I. Gold in murine dystrophy. Journal of Neurology Neurosurgery and Psychiatry, 41(5), 404-407. https://doi.org/10.1136/jnnp.41.5.404

@article{3aa5f07fa209467db3bf8a1df7efadf9,

title = "Therapeutic trials in muscular dystrophy. I. Gold in murine dystrophy",

abstract = "A trial of sodium aurothiomalate as an antiproteinase drug in the treatment of murine muscular dystrophy is reported. A blind controlled comparison of high (25 μg/10 g body weight) and low dose gold (5 μg/10 g body weight) with saline-injected control animals was made, all injections being given 3 times weekly. The body weights and functional ability of the mice were assessed at weekly intervals. No significant difference between the groups was observed. A trial of very high dose chrysotherapy (500 μg of gold/10 g body weight) also showed no therapeutic benefit.",

author = "A. Enomoto and Bradley, {W. G.}",

year = "1978",

doi = "10.1136/jnnp.41.5.404",

language = "English (US)",

volume = "41",

pages = "404--407",

journal = "Journal of Neurology, Neurosurgery and Psychiatry",

issn = "0022-3050",

publisher = "BMJ Publishing Group",

number = "5",

}

TY - JOUR

T1 - Therapeutic trials in muscular dystrophy. I. Gold in murine dystrophy

AU - Enomoto, A.

AU - Bradley, W. G.

PY - 1978

Y1 - 1978

N2 - A trial of sodium aurothiomalate as an antiproteinase drug in the treatment of murine muscular dystrophy is reported. A blind controlled comparison of high (25 μg/10 g body weight) and low dose gold (5 μg/10 g body weight) with saline-injected control animals was made, all injections being given 3 times weekly. The body weights and functional ability of the mice were assessed at weekly intervals. No significant difference between the groups was observed. A trial of very high dose chrysotherapy (500 μg of gold/10 g body weight) also showed no therapeutic benefit.

AB - A trial of sodium aurothiomalate as an antiproteinase drug in the treatment of murine muscular dystrophy is reported. A blind controlled comparison of high (25 μg/10 g body weight) and low dose gold (5 μg/10 g body weight) with saline-injected control animals was made, all injections being given 3 times weekly. The body weights and functional ability of the mice were assessed at weekly intervals. No significant difference between the groups was observed. A trial of very high dose chrysotherapy (500 μg of gold/10 g body weight) also showed no therapeutic benefit.

UR - http://www.scopus.com/inward/record.url?scp=0017879727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017879727&partnerID=8YFLogxK

U2 - 10.1136/jnnp.41.5.404

DO - 10.1136/jnnp.41.5.404

M3 - Article

C2 - 96218

AN - SCOPUS:0017879727

VL - 41

SP - 404

EP - 407

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 5

ER -